Studying “brake failure” in thyroid cancer metastasis
Adolescents and adults of all ages find comprehensive care – including high-tech treatment and research programs – at The Ohio State University Wexner Medical Center’s growing Adult Type 1 Diabetes (T1D) Program.
The program receives approximately 30 new patient referrals per month. This includes those transitioning to adult care, new to the area and also newly diagnosed adults who were initially misdiagnosed with type 2 diabetes (T2DM).
“Our goal is to empower patients to successfully incorporate [type 1 diabetes] care into their lives,” explains Kathleen Wyne, MD, PhD. “Disease management requires careful balance of insulin dosing, food intake and activity levels – which can change daily, weekly and seasonally.”
As technology evolves, patients access the latest care methods, including continuous glucose monitoring tools, insulin delivery devices, new insulins and non-insulin agents.
“We routinely review glucose monitoring and insulin delivery devices at all visits,” says Kathleen Dungan, MD. “Patients are encouraged to link their devices to our clinic accounts and share from home.”
Diabetes device clinics offer streamlined care and education in the same visit and demonstrate a significant reduction in A1C.
The program offers:
-
Clinical trials that utilize advanced glucose monitoring technologies, state-of-the-art insulin delivery devices and new therapies
-
Screening of high-risk family members through the TrialNet study
Young Adult Diabetes Transition Program
To support young T1D patients as they grow up, Ohio State Wexner Medical Center works closely with Nationwide Children’s Hospital.
Patients receive counseling about substance use, preconception planning and pregnancy, social and work accommodations, and mental health resources.
The College Diabetes Network chapter at Ohio State supports the college students as they transition to independent care away from home.
Special Pregnancy Care for Women with Type 1 Diabetes
For pregnant women with type 1 diabetes, thyroid disease and other endocrine disorders, Elizabeth Buschur, MD, and her colleagues offer specialized care. Dr. Buschur sees these women in the Ob/Gyn clinic so that they do not have to make an extra clinic visit. Dr. Buschur is the site principal investigator for a study examining hybrid closed-loop insulin pump therapy versus sensor-augmented pump therapy to manage blood glucose during pregnancy.
